Background The physiopathology of dengue hemorrhagic fever (DHF), a severe form of Dengue Fever, is poorly understood. We are unable to identify patients likely to progress to DHF for closer monitoring and early intervention during epidemics, so most cases are sent home. This study explored whether patients with selected co-morbidities are at higher risk of developing DHF. Methods A matched case-control study was conducted in a dengue sero-positive population in two Brazilian cities. For each case of DHF, 7 sero-positive controls were selected. Cases and controls were interviewed and information collected on demographic and socio-economic status, reported co-morbidities (diabetes, hypertension, allergy) and use of medication. Conditional logistic regression was used to calculate the strength of the association between the co-morbidities and occurrence of DHF. Results 170 cases of DHF and 1,175 controls were included. Significant associations were found between DHF and white ethnicity (OR = 4.70; 2.17–10.20), high income (OR = 6.84; 4.09–11.43), high education (OR = 4.67; 2.35–9.27), reported diabetes (OR = 2.75; 1.12–6.73) and reported allergy treated with steroids (OR = 2.94; 1.01–8.54). Black individuals who reported being treated for hypertension had 13 times higher risk of DHF then black individuals reporting no hypertension. Conclusions This is the first study to find an association between DHF and diabetes, allergy and hypertension. Given the high case fatality rate of DHF (1–5%), we believe that the evidence produced in this study, when confirmed in other studies, suggests that screening criteria might be used to identify adult patients at a greater risk of developing DHF with a recommendation that they remain under observation and monitoring in hospital.
References
[1]
Dengue fever climbs the social ladder [editorial] (2007) Nature Aug 448: 734–35. doi: 10.1038/448734a
Guzman MG, Kourí G (2002) Dengue: an update. Lancet Infect Dis 2(1): 33–42. doi: 10.1016/S1473-3099(01)00171-2
[4]
World Health Organization (2008) Impact of dengue [on line]. Acessed in: http://www.who.int/csr/disease/dengue/im？pact/en/index.html.
[5]
Halstead SB (2006) Dengue in the Americas and Southeast Asia: do they differ? Rev Panam Salud Publica 6: 407–15. doi: 10.1590/S1020-49892006001100007
[6]
Teixeira MG, Costa MCN, Coelho G, Barreto M (2008) Recent Shift in Age Pattern of dengue Hemorrhagic Fever, Brazil. Emerg Infect Dis 2008 14(10): 1663. doi: 10.3201/eid1410.071164
[7]
Barreto M, Teixeira MG (2008) Dengue fever: a call for local, national, and international action. Lancet 2008 372(9634): 205. doi: 10.1016/s0140-6736(08)61069-7
[8]
Halstead SB (1981) The pathogenesis of dengue: Molecular Epidemiology in Infections Disease. Am J Epidemiol 114(5): 632–48.
Teixeira MG, Costa MCN, Barreto ML, Mota E (2005) Dengue and dengue hemorrhagic fever epidemics in Brazil: what research is needed based on trends, surveillance, and control experiences? Cad Saúde Pública 21(5): 1307–15. doi: 10.1590/s0102-311x2005000500002
[11]
Kourí GP, Guzman MG, Bravo JR (1987) Why dengue haemorrhagic fever in Cuba? An integral analysis. Trans R Soc Trop Med Hyg 81(5): 821–23. doi: 10.1016/0035-9203(87)90042-3
[12]
Cunha RV, Schatzmayr HG, Miagostovich MP, Barbosa AMA, Paiva FG, et al. (1999) Dengue epidemic in the State of Rio Grande do Norte, Brazil, 1997. Trans R Soc Trop Med Hyg 93: 247–49. doi: 10.1016/S0035-9203(99)90008-1
[13]
Brasil Funda？？o Nacional de Saúde (2002) Dengue: diagnóstico e manejo clínico. – Brasília: Funda？？o Nacional de Saúde. 28 p.
[14]
World Health Organization (1997) Dengue Haemorrhagic fever: diagnosis, treatment, prevention and control, 2edn. Geneva: World Health Organization.
[15]
Chungue E, Marché R, Plichart J, Bovin JP, Roux J (1989) Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG–ELISA) and hemagglutination inhibition (HI) test for the detection of dengue antibodies. Prevalence of dengue IgG–ELISA antibodies in Tahiti. Trans R Soc Trop Med Hyg 83(5): 708–711. doi: 10.1016/0035-9203(89)90404-5
[16]
Greenland S (1998) Applications of stratified analysis methods. In: Rothman KJ, Greenland S, editors. Modern Epidemiology, chapter 16. 2nd ed. Philadelphia, USA: pp. 281–300.
[17]
Sierra B de la C, Koury G, Guzmán MG (2007) Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152: 533–42. doi: 10.1007/s00705-006-0869-x
[18]
Blanton RE, Silva LK, Morato VG, Parrado AR, Dias JP, et al. (2008) Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population. Eur J Hum Genet 13: 15–8. doi: 10.1038/ejhg.2008.4
[19]
Brown JM, Wilson TM, Metcalfe DD (2008) The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy Jan 38(1): 4–18. doi: 10.1111/j.1365-2222.2008.03000.x
[20]
Trivedi SG, Lloyd CM (2007) Eosinophils in the pathogenesis of allergic airways disease. Cell Mol Life Sci May 64(10): 1269–89. doi: 10.1007/s00018-007-6527-y
[21]
Hsueh WA, Lyon CJ, Qui？ones MJ (2004) Insulin resistance and the endothelium. Am J Med 117: 109–17. doi: 10.1016/j.amjmed.2004.02.042
[22]
Dandona P, Alijada A, Chaudhuri A, Mohanty P (2004) Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Dis 5: 189–97.
[23]
Stephenson JR (2005) Understanding dengue pathogenesis: implications for vaccine design. Bull Word Health Organ Apr 83(4): 308–14.
[24]
Instituto Brasileiro de Geografia e Estatística (2008) [on line] Accessed in: http://www.ibge.gov.br/home/estatística/popula？？o/default-censo.
[25]
Woolcock AJ, Peat JK (1997) Evidence for the increase in asthma worldwide. Ciba Found Symp 206: 122–34. doi: 10.1002/9780470515334.ch8
[26]
Upton MN, McConnachie A, McSharry C, Hart CL, Smith GD, et al. (2000) Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring. BMJ 321: 88–92. doi: 10.1136/bmj.321.7253.88
[27]
Williams HC (1992) Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 17: 385–391. doi: 10.1111/j.1365-2230.1992.tb00244.x
[28]
Von Hertzen LC, Haahtela T (2004) Asthma and atopy - the price of affluence? Allergy 59(2): 124–37. doi: 10.1046/j.1398-9995.2003.00433.x
[29]
Schaub B, Lauener R, von Mutius E (2006) The many faces of the hygiene hypothesis. J Allergy Clin Immunol 117(5): 969–78. doi: 10.1016/j.jaci.2006.03.003
[30]
Sierra BC, Garcia G, Perez AB, Morrier L, Alvarez M, et al. (2006) Ethnicity and difference in dengue virus-specific memory T cell responses in Cuban individuals. Viral Immunol 19: 662–668. doi: 10.1089/vim.2006.19.662
[31]
Vasconcelos PFC, Lima JWO, Travassos da Rosa PA, Timbó MJ, Travassos da Rosa ES, et al. (1998) Epidemia de dengue em Fortaleza, Ceará: inquérito soroepidemiológico aleatório. Rev Saúde Pública 32(5): 447–454. doi: 10.1590/s0034-89101998000500007
[32]
Teixeira MG, Barreto ML, Costa MCN, Ferreira LDA, Vasconcelos PFC, et al. (2002) Dynamics of dengue virus circulating: a silent epidemics in a complex urban area. Trop Med International Health 7(9): 757–762. doi: 10.1046/j.1365-3156.2002.00930.x
